Valued at a market cap of $143.8 billion, Gilead Sciences, Inc. (GILD) is a biopharmaceutical company that discovers, ...
The pharmaceutical powerhouse has two drugs that disrupt the transmission of the virus, one of which has been approved for ...
Biopharmaceutical stocks that have lagged behind the broader market may finally have their day in the sun. BofA Securities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback